Preparing for Gene Therapy Starts with Understanding Immunity – WFH
World Federation of Hemophilia – WFH shared a post on LinkedIn about a recent article by Hubert Darius J Daniel et al., published in Human Gene Therapy, adding:
“Preparing for gene therapy starts with understanding immunity.
This study examines baseline AAV antibody levels among people with and without hemophilia in India, informing screening approaches and access planning.”
Title: Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India
Authors: Hubert Darius J Daniel, Jaffar Farzana, Rajesh Kannangai, Sanjay Kumar, Kavitha M Lakshmi, Charnitkaur B Jashal, Hemant Dhamne, Varun Lahoti, Deepak Kanjwani, Aby Abraham, Kirsten Coleman, Arun Srivastava, Alok Srivastava, Asha Mary Abraham
More posts about World Federation of Hemophilia on Hemostasis Today.
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines